论文部分内容阅读
近年来,手术、化疗、放疗在胃癌治疗方面取得了一定的进步,然而进展期胃癌疗效仍不理想。靶向治疗在胃癌的应用逐渐受到越来越多的关注。目前,已有众多的Ⅱ/Ⅲ期临床试验用于评估胃癌分子靶向治疗疗效,针对Her-2的分子靶向治疗已取得突破性进展,更多的靶点和靶向药物有待发掘。
In recent years, surgery, chemotherapy, radiotherapy have made some progress in the treatment of gastric cancer, however, the efficacy of advanced gastric cancer is still not ideal. The application of targeted therapy in gastric cancer is receiving more and more attention. At present, there are a large number of phase Ⅱ / Ⅲ clinical trials for evaluating the efficacy of molecular targeted therapy for gastric cancer, and breakthroughs have been made in the molecular targeted therapy of Her-2. More targets and targeted drugs remain to be discovered.